Advertisement
Advertisement

CNSP

CNSP logo

CNS Pharmaceuticals, Inc. Common Stock

5.13
USD
Sponsored
-0.25
-4.65%
Aug 10, 13:08 UTC -4
Closed
exchange

After-Market

5.31

+0.18
+3.51%

CNS Pharmaceuticals, Inc. Common Stock Profile

About

CNS Pharmaceuticals Inc. is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. The company's lead drug includes Berubicin, for the treatment of Glioblastoma Multiforme and potentially for other CNS malignancies. CNS Pharmaceuticals Inc. is based in Houston, United States.

Info & Links

CEO

Rami Levin

Headquarters

2100 WEST LOOP SOUTH, SUITE 900
HOUSTON, TX 77027, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cnspharma.com

Auditor

MaloneBailey, LLP

Share holders

5

Employees

8

CNS Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

7.76M

Enterprise Value

5.04M

Enterprise Value/EBITDA(ttm)

-0.30

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

61.74

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-238.68%

Return on Invested Capital(ttm)

-7164.86%

Return on Assets(ttm)

-166.30%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-16.62M

Net Income Available to Common(ttm)

-16.49M

Diluted EPS(ttm)

-29.63

Share Statistics

Beta (5Y Monthly)

3.05

52-Week Change

-23.43%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

1.46M

Dividend Yield

0.00%

Float4

1.46M

% Held by Insiders

0.01%

% Held by Institutions

14.02%

Balance Sheet

Total Cash(mrq)

2.95M

Total Cash Per Share(mrq)

2.02

Total Debt(mrq)

232.40K

Total Debt/Equity(mrq)

328.62%

Current Ratio(mrq)

0.89%

Quick Ratio(mrq)

0.89%

Book Value Per Share(mrq)

0.09

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.88

Free Cash Flow(ytd)

-4.65M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement